In addition, to analyse the impact of ApoB-BD modification we also compared the behavioural exploratory phenotype of MPS-IIIA mice treated with fully modified sulphamidase with that of MPS-IIIA mice treated with partially modified sulphamidase. This evidence concerns the gene SGSH and mucopolysaccharidosis type 3A.